Open Access Repository
Comment: Increased sensitivity to warfarin after heart valve replacement
![]() |
PDF
comment_warfari...pdf | Request a copy Full text restricted Available under University of Tasmania Standard License. |
Abstract
TO THE EDITOR: In their recent article in The Annals, Rahman et al
concluded that after cardiac valve replacement, patients are more sensitive
to warfarin and should receive a lower dose during the initial phase
of treatment. In that study, all patients received 5 mg of warfarin for the
first 2 days following surgery. A regimen using 2.5 mg of warfarin for
the first 2 days after surgery in such patients has been suggested; this
regimen has been shown to cause a reduced incidence of elevated international
normalized ratio (INR) during initiation. Rahman et al. noted
that "during initiation of oral anticoagulation following heart valve replacement,
patients have a tendency to exceed the upper limit of the targeted
INR range despite regular monitoring," and reported that 25% of
their patients had an INR higher than 4 during initiation.
Item Type: | Article |
---|---|
Authors/Creators: | Bereznicki, LRE and Jackson, SL |
Journal or Publication Title: | The Annals of Pharamcotherapy |
Publisher: | Harvey Whitney Books Company |
ISSN: | 1060-0280 |
Item Statistics: | View statistics for this item |
Actions (login required)
![]() |
Item Control Page |